Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning balance (in shares) at Dec. 28, 2019 2,771 36,167          
Beginning balance at Dec. 28, 2019 $ 3 $ 38 $ 187,147 $ (7,146) $ 214 $ (167,876) $ 12,380
Increase (Decrease) in Stockholders' Equity              
Net income (loss)           (978) (978)
Issuance of shares in connection with stock option exercise   $ 1 1,119       1,120
Issuance of shares in connection with stock option exercise (in shares)   523          
Issuance of shares in connection with restricted stock units vesting   $ 2 (86)       (84)
Issuance of shares in connection with restricted stock units vesting (in shares)   1,809          
Issuance of shares in connection with BOD Fees     6       6
Issuance of shares in connection with BOD Fees (in shares)   3          
Share-based compensation     2,819       2,819
Common stock dividend on preferred stock     38     (39) (1)
Common stock dividend on preferred stock (in shares)   20          
Conversion of preferred stock (in shares) (150) 150          
Unrealized (loss) gain on deferred compensation trust assets         (95)   (95)
Effect of changes in foreign currencies         (6)   (6)
Ending balance (in shares) at Mar. 28, 2020 2,621 38,672          
Ending balance at Mar. 28, 2020 $ 3 $ 41 191,043 (7,146) 113 (168,893) 15,161
Beginning balance (in shares) at Dec. 28, 2019 2,771 36,167          
Beginning balance at Dec. 28, 2019 $ 3 $ 38 187,147 (7,146) 214 (167,876) 12,380
Increase (Decrease) in Stockholders' Equity              
Net income (loss)             590
Ending balance (in shares) at Jun. 27, 2020   42,411          
Ending balance at Jun. 27, 2020   $ 45 194,693 (7,146) 142 (167,358) 20,376
Beginning balance (in shares) at Mar. 28, 2020 2,621 38,672          
Beginning balance at Mar. 28, 2020 $ 3 $ 41 191,043 (7,146) 113 (168,893) 15,161
Increase (Decrease) in Stockholders' Equity              
Net income (loss)           1,568 1,568
Issuance of shares in connection with stock option exercise   $ 1 1,772       1,773
Issuance of shares in connection with stock option exercise (in shares)   907          
Issuance of shares in connection with restricted stock units vesting     (2)       (2)
Issuance of shares in connection with restricted stock units vesting (in shares)   183          
Issuance of shares in connection with BOD Fees     6       6
Issuance of shares in connection with BOD Fees (in shares)   3          
Share-based compensation     1,874       1,874
Common stock dividend on preferred stock           (33) (33)
Common stock dividend on preferred stock (in shares)   25          
Conversion of preferred stock $ (3) $ 3          
Conversion of preferred stock (in shares) (2,621) 2,621          
Unrealized (loss) gain on deferred compensation trust assets         58   58
Effect of changes in foreign currencies         (29)   (29)
Ending balance (in shares) at Jun. 27, 2020   42,411          
Ending balance at Jun. 27, 2020   $ 45 194,693 (7,146) 142 (167,358) 20,376
Beginning balance (in shares) at Jan. 02, 2021 0 48,091          
Beginning balance at Jan. 02, 2021 $ 0 $ 51 260,260 (7,146) (215) (169,461) 83,489
Increase (Decrease) in Stockholders' Equity              
Net income (loss)           (2,722) (2,722)
Issuance of shares in connection with stock option exercise     163       163
Issuance of shares in connection with stock option exercise (in shares)   130          
Issuance of shares in connection with restricted stock units vesting   $ 2 (6)       (4)
Issuance of shares in connection with restricted stock units vesting (in shares)   2,382          
Issuance of shares in connection with BOD Fees     6       6
Share-based compensation     4,080       4,080
Unrealized (loss) gain on deferred compensation trust assets         35   35
Effect of changes in foreign currencies         14   14
Ending balance (in shares) at Apr. 03, 2021   50,603          
Ending balance at Apr. 03, 2021   $ 53 264,503 (7,146) (166) (172,183) 85,061
Beginning balance (in shares) at Jan. 02, 2021 0 48,091          
Beginning balance at Jan. 02, 2021 $ 0 $ 51 260,260 (7,146) (215) (169,461) 83,489
Increase (Decrease) in Stockholders' Equity              
Net income (loss)             $ (650)
Issuance of shares in connection with stock option exercise (in shares)             1,593
Ending balance (in shares) at Jul. 03, 2021   52,184          
Ending balance at Jul. 03, 2021   $ 55 271,334 (7,146) (112) (170,111) $ 94,020
Beginning balance (in shares) at Apr. 03, 2021   50,603          
Beginning balance at Apr. 03, 2021   $ 53 264,503 (7,146) (166) (172,183) 85,061
Increase (Decrease) in Stockholders' Equity              
Net income (loss)           2,072 2,072
Issuance of shares in connection with stock option exercise   $ 2 2,615       2,617
Issuance of shares in connection with stock option exercise (in shares)   1,463          
Issuance of shares in connection with restricted stock units vesting     389       389
Issuance of shares in connection with restricted stock units vesting (in shares)   118          
Issuance of shares in connection with BOD Fees     6       6
Share-based compensation     3,821       3,821
Unrealized (loss) gain on deferred compensation trust assets         38   38
Effect of changes in foreign currencies         16   16
Ending balance (in shares) at Jul. 03, 2021   52,184          
Ending balance at Jul. 03, 2021   $ 55 $ 271,334 $ (7,146) $ (112) $ (170,111) $ 94,020